In our model, the significant decrease of DNAJB3 in obese subjects, its correlation with inflammatory markers and fat levels and the restoration of its normal expression after a defined exercise protocol suggest that DNAJB3 might potentially play a protective role in obesity, insulin resistance and T2D. The gene discussed is DNAJB3; the disease is obesity due to melanocortin 4 receptor deficiency.